Metabolic disease

There are 1,269 papers on metabolic disease in aging research: 40 trials and 269 observational studies in people, 133 in animals, 1 in cells, 791 reviews.

Disease

1,269 papers study it1,418 more mention it151 findings

MeSH

159 new papers in 30 daysSee all 2,687 papers on metabolic disease

At a glance

Metabolic disease is linked with higher vascular dementia risk and worse cognitive function in human studies. Obesity, including in older adults, and vitamin B12 or D deficiency in patients with obesity are associated with metabolic disease. In mice, time-restricted feeding protects circadian clock knockout animals, while nicotinamide riboside protects against high-fat diet-induced metabolic disease.

151 findings in 138 papers from 2012 to 2026, 23 of them since April 2026

“Animal-food diet is associated with a range of metabolic diseases”
Identification of Chinese dietary patterns and their relationships with health outcomes: a systematic review and meta-analysisPublic health nutrition2024doi:10.1017/s1368980024001927
  • Human trial40
  • Humans269
  • Animals129
  • Model organisms4
  • Cells1
  • In silico24

Interventions

30

Exercise

downin reviews2downin humans1

3 studies
  1. Exercise decreases metabolic disease (physical activity combined with calorie restriction).

    “Physical activity combined with calorie restriction can effectively reduce metabolic disease and chronic inflammation, alleviating the adverse effects of weight cycling on the body.”

    Reviewphysical activity combined with calorie restriction

    The Impact of Weight Cycling on Health and Obesity

    Metabolites

  2. Exercise decreases metabolic disease in advancing ageing and age-related diseases.

    “exercise alleviates metabolic diseases in individuals with advancing ageing and age-related diseases by the remarkable promotion of mitochondrial biogenesis and function”

    Reviewin advancing ageing and age-related diseases

    Exercise mitigates age-related metabolic diseases by improving mitochondrial dysfunction

    Ageing research reviews

  3. Exercise protects against metabolic disease in humans.

    “Exercise drives metabolic integration between muscle, adipose and liver metabolism and protects against aging-related diseases”

    Review

    Exercise drives metabolic integration between muscle, adipose and liver metabolism and protects against aging-related diseases

    Experimental gerontology

More on Exercise

Lifestyle modification

downin humans2

2 studies
  1. Lifestyle modification protects against metabolic disease in patients with mental disorders treated with antipsychotics.

    “The basis of prevention is lifestyle modification through small, gradual steps easier to maintain over the long term.”

    Reviewin patients with mental disorders treated with antipsychotics

    Reducing the risk of obesity, diabetes, and metabolic disorders in patients treated with antipsychotics - recommendations of the Polish Psychiatric Association Part I: risk factors and psychological interventions

    Psychiatria polska

  2. Lifestyle modification prevents metabolic disease in humans.

    “Public health interventions targeting modifiable risk factors can effectively promote healthier lifestyles and prevent metabolic diseases.”

    Review

    Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health

    Frontiers in public health

More on Lifestyle modification

Berberine

downin reviews2

2 studies
  1. Berberine decreases metabolic disease.

    “Studies have shown that BBR can alleviate the pathological conditions of metabolic disorders, and the mechanism is related to the regulation of gut microbiota”

    Review

    The mechanism of berberine alleviating metabolic disorder based on gut microbiome

    Frontiers in cellular and infection microbiology

  2. Berberine protects against metabolic disease.

    “Lycopene and berberine are natural plants with a wide range of beneficial effects including protective activities against metabolic disorders such as diabetes and cardiovascular diseases.”

    Review

    Berberine and lycopene as alternative or add-on therapy to metformin and statins, a review

    European journal of pharmacology

More on Berberine

Caloric restriction

downin reviews2

2 studies
  1. Caloric restriction prevents metabolic disease.

    “In addition to preventing metabolic disorders”

    Review

    Beneficial Effects on Brain Micro-Environment by Caloric Restriction in Alleviating Neurodegenerative Diseases and Brain Aging

    Frontiers in physiology

  2. Caloric restriction prevents metabolic disease.

    “Caloric restriction helps to prevent such metabolic disorders”

    Review

    Effect of Caloric Restriction on Aging: Fixing the Problems of Nutrient Sensing in Postmitotic Cells?

    Biochemistry. Biokhimiia

More on Caloric restriction

Metformin

downin humans1

1 study
  1. Metformin prevents metabolic disease in humans.

    “consideration should be given to the introduction of metformin treatment at a dose of 1,000-2,000 mg/day, as the best-documented, safe, and inexpensive pharmacological method for preventing the development of metabolic disorders”

    Reviewin patients receiving antipsychotics with weight gain, diagnostic abnormalities, metabolic risk factors, or high metabolic risk APs1,000-2,000 mg/day

    Reducing the risk of obesity, diabetes, and metabolic disorders in patients treated with antipsychotics - recommendations of the Polish Psychiatric Association Part II: diagnostics and pharmacological treatment

    Psychiatria polska

More on Metformin

Taurine

downin reviews1

1 study
  1. Taurine protects against metabolic disease.

    “the protective effects and molecular mechanisms of taurine in metabolism‐related diseases such as diabetes”

    Review

    Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications

    Food Frontiers

More on Taurine

Organoid therapy

downin reviews1

1 study
  1. Organoid therapy decreases metabolic disease.

    “engineered organoids have been successfully applied to restore hair-bearing skin, repair colonic epithelial continuity, bridge critical-size bone defects, and correct metabolic disorders.”

    Reviewengineered

    Engineering organoids toward implantable living therapeutics

    hLife

More on Organoid therapy

Circadian rhythm disruption combined with a high-fat, high-sugar diet

upin mice1

1 study
  1. Circadian rhythm disruption combined with a high-fat, high-sugar diet increases metabolic disease in mice.

    “Compared with controls, the composite model showed more severe metabolic disorders, including increased body weight, elevated fasting glucose and lipid levels, and marked hepatic steatosis”

    ReviewC57BL/6J composite model compared with single-factor high-fat, high-sugar diet and circadian disruption controls

    A Combinatorial Mouse Model of Circadian Disruption and Dietary Stress for Investigating Lifestyle-Accelerated Aging Pathophysiology

    Journal of visualized experiments : JoVE

More on Circadian rhythm disruption combined with a high-fat, high-sugar diet

Stem cell therapy

downin reviews1

1 study
  1. Stem cell therapy decreases metabolic disease.

    “the application of SCs along with antioxidants, to mitigate oxidative stress-induced metabolic disorders.”

    Review

    ROS-associated metabolic disorders: Molecular mechanism and stem cell therapy

    Pathology, research and practice

More on Stem cell therapy

FOXO-targeting compounds

downin reviews1

1 study
  1. FOXO-targeting compounds decrease metabolic disease.

    “These FOXO-targeting compounds demonstrate great potential in improving metabolic disorders and delaying the onset of aging phenotypes.”

    Review

    FOXO: a key target in regulating aging and age-related diseases

    Biogerontology

More on FOXO-targeting compounds

All 30

Effects

9

Muscle echointensity

upin humans1

1 study
  1. Metabolic disease is linked with higher muscle echointensity in humans (compared to the control group) (p < 0.05).

    “The tibialis anterior muscle had higher echointensity values in the metabolic disease group ( p < 0.05).”

    Humanscompared to the control grouptibialis anterior musclen = 68

    Ultrasound assessment of skeletal muscles in patients with metabolic diseases and in healthy individuals over 45 years of age

    Сибирский журнал клинической и экспериментальной медицины

More on Muscle echointensity

Muscle mass

downin humans1

1 study
  1. Metabolic disease is linked with lower muscle mass in humans (compared to the control group).

    “the rectus femoris was characterized by decreased pennation angle, anatomical cross-sectional area (CSA), physiological CSA, and muscle volume”

    Humanscompared to the control grouprectus femorisn = 68

    Ultrasound assessment of skeletal muscles in patients with metabolic diseases and in healthy individuals over 45 years of age

    Сибирский журнал клинической и экспериментальной медицины

Trabecular bone score

downin humans1

1 study
  1. Metabolic disease is linked with lower trabecular bone score in patients with Turner syndrome.

    “The presence of metabolic diseases appeared to have a negative influence on TBS (p=0.034).”

    Humansin patients with Turner syndromefemales

    Impact of Clinical Factors on Bone Microarchitecture in Patients with Turner Syndrome

    Endocrine, metabolic & immune disorders drug targets

More on Trabecular bone score

Physiological decline

upin reviews1

1 study
  1. Metabolic disease induces physiological decline.

    “Aging and metabolic diseases are intricately linked through bidirectional molecular mechanisms that foster a harmful cycle of physiological decline.”

    Review

    Interplay between aging and metabolic diseases: from molecular mechanisms to therapeutic horizons

    Medical review (2021)

Extracellular vesicle secretion

downin reviews1

1 study
  1. Metabolic disease impairs extracellular vesicle secretion.

    “aging and metabolic diseases impair EV biogenesis and secretion”

    Review

    Mechanisms of Exercise‐Induced Skeletal Muscle Extracellular Vesicle Secretion and Their Physiological Functions: A Review

    Preprints.orgPreprint

More on Extracellular vesicle secretion

Cognitive function

downin humans1

1 study
  1. Metabolic disease is linked with worse cognitive function in humans (particularly diabetes and hypertension).

    “Metabolic disorders-particularly diabetes and hypertension-were associated with worse cognitive performance”

    Humansparticularly diabetes and hypertension

    The interplay between metabolic health factors and stroke incidence in aging populations

    Frontiers in endocrinology

Ovarian aging

upin reviews1

1 study
  1. Metabolic disease increases ovarian aging.

    “It has been reported that metabolic disorder may significantly contribute to ovarian aging.”

    Review

    Metabolic disorder: the dark side of ovarian aging

    Trends in molecular medicine

Bioactivity of adult-derived mesenchymal stem cells

downin reviews1

1 study
  1. Metabolic disease impairs bioactivity of adult-derived mesenchymal stem cells.

    “aging and metabolic diseases negatively impact the bioactivity of adult-derived MSCs”

    Review

    "Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial"

    Frontiers in cell and developmental biology

Cellular senescence

upin reviews1

1 study
  1. Metabolic disease induces cellular senescence.

    “metabolic diseases, which in turn promote senescence.”

    Review

    The metabolic roots of senescence: mechanisms and opportunities for intervention

    Nature metabolism

More on Cellular senescence

Upstream

10

Metabolic flexibility

downin reviews1

1 study
  1. metabolic flexibility protects against metabolic disease.

    “Its remarkable capacity for dynamic adaptation, termed metabolic flexibility, underpins physical performance and protects against metabolic diseases such as obesity, type 2 diabetes, and sarcopenia.”

    Reviewskeletal muscle

    Skeletal muscle metabolism in health and disease: Mechanisms, interventions, and clinical perspectives

    iScience

YY1

upin mice1

1 study
  1. YY1 increases metabolic disease in mice (on high-fat diet; shown by adipocyte-specific knockout).

    “YAKO mice showed alleviation of HFD-induced metabolic disorders”

    Animalson high-fat diet; shown by adipocyte-specific knockout

    Blocking Adipocyte YY1 Decouples Thermogenesis From Beneficial Metabolism by Promoting Spermidine Production

    Diabetes

More on YY1

TERT

downin mice1

1 study
  1. TERT decreases metabolic disease in obesity.

    “Conditional expression of mTERT reduces metabolic disorders associated with obesity.”

    Animalsin obesity

    TERT prevents obesity-induced metabolic disorders by promoting adipose stem cell expansion and differentiation

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on TERT

TFEB

downin mice1

1 study
  1. TFEB prevents metabolic disease in mice (shown by proximal tubule-specific Tfeb knockout).

    “TFEB deficiency in the proximal tubules caused metabolic disorders and occasionally led to apolipoprotein A4 (APOA4) amyloidosis”

    Animalsshown by proximal tubule-specific Tfeb knockoutproximal tubules

    Age-related TFEB downregulation in proximal tubules causes systemic metabolic disorders and occasional apolipoprotein A4-related amyloidosis

    JCI insight

More on TFEB

cd24-siglec-e axis

downin mice1

1 study
  1. cd24-siglec-e axis protects against metabolic disease in mice (diet-induced metabolic disorders).

    “Inactivation of the CD24-Siglec-E pathway exacerbates, while CD24Fc treatment alleviates, diet-induced metabolic disorders, including obesity, dyslipidemia, insulin resistance, and nonalcoholic steatohepatitis (NASH).”

    Animalsdiet-induced metabolic disorders

    CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder

    Cell metabolism

Sphingosine-1-phosphate

mediatesin reviews1

1 study
  1. Sphingosine-1-phosphate mediates metabolic disease.

    “changes in the S1P axis (i.e., S1P production, transport, and receptors) may modify metabolism and eventually mediate metabolic diseases.”

    Review

    Sphingosine-1-phosphate in mitochondrial function and metabolic diseases

    Obesity reviews : an official journal of the International Association for the Study of Obesity

More on Sphingosine-1-phosphate

Inflammation

upin reviews1

1 study
  1. Inflammation induces metabolic disease under metabolic stress.

    “This activation of different cell types in the hypothalamus leads to chronic, low-grade inflammation, impairing energy balance and contributing to defective feeding habits, thermogenesis, and insulin and leptin signaling, eventually leading to metabolic disorders”

    Reviewunder metabolic stress

    Hypothalamic inflammation in metabolic disorders and aging

    Cellular and molecular life sciences : CMLS

More on Inflammation

Gut dysbiosis

upin reviews1

1 study
  1. Gut dysbiosis induces metabolic disease.

    “gut dysbiosis can trigger metabolic diseases”

    Review

    Modifiable Risk Factors for Dementia: The Role of Gut Microbiota

    Current Alzheimer research

More on Gut dysbiosis

SIRT6

downin reviews1

1 study
  1. SIRT6 protects against metabolic disease.

    “SIRT6 protects against aging-associated pathologies including metabolic disease and cancer”

    Review

    SIRT6: Novel Mechanisms and Links to Aging and Disease

    Trends in endocrinology and metabolism: TEM

More on SIRT6

PLIN2

downin mice1

1 study
  1. PLIN2 decreases metabolic disease in mice (downregulation).

    “In particular, its downregulation in mice prevents or mitigates some of the above mentioned diseases.”

    Reviewdownregulation

    Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective

    Trends in endocrinology and metabolism: TEM

More on PLIN2

Associations

82

Mortality

upin humans4HR 1.1

4 studies
  1. Metabolic disease is associated with mortality in humans (upper gastrointestinal cancer) (from 2.0 to 4.2 per 100,000).

    “Overall AAMRs increased from 2.0 to 4.2 per 100,000, with a significant rise from 1999 to 2009 (APC 4.30%; 95% CI, 2.97–5.56; p < 0.01)”

    Humansupper gastrointestinal cancer1999-2020n = 45,086

    Trends and disparities in upper gastrointestinal cancer among patients with metabolic comorbidities: a retrospective CDC-WONDER analysis (1999–2020)

    BMC public health

  2. Metabolic disease is linked with a higher risk of mortality in humans (advanced non-small cell lung cancer) (HR 1.10, 95% CI 1.04-1.16).

    “Veterans with metabolic diseases (24.7% of all patients; hazard ratio [HR] [95% confidence interval (CI)], 1.10 [1.04-1.16])”

    Humansadvanced non-small cell lung cancern = 10,160

    Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer

    Annals of the American Thoracic Society

  3. Metabolic disease is associated with mortality in humans after free-flap reconstruction (Alive: 33.90% vs. Dead: 54.50%; p = 0.031).

    “metabolic diseases (Alive: 33.90% vs. Dead: 54.50%; p = 0.031) more frequently”

    Humansafter free-flap reconstructionn = 147

    Analysis of Factors Determining Patient Survival after Receiving Free-Flap Reconstruction at a Single Center-A Retrospective Cohort Study

    Diagnostics (Basel, Switzerland)

  4. Metabolic disease raises the risk of mortality in humans.

    “Data suggest that SARS-CoV-2 patients with concomitant metabolic diseases had higher risk of worse prognosis and mortality.”

    Review

    Covid-19 Pandemic and Metabolic Aging

    Acta scientific neurology

Obesity

upin humans3

3 studies
  1. Obesity is associated with metabolic disease in humans (p < 0.05).

    “Obesity based on waist circumference was significantly positively associated with all metabolic diseases (all, p < 0.05).”

    Humans

    Age-wise examination of the association of obesity based on body mass index and waist circumference with metabolic diseases in comprehensive health checkup participants

    Obesity science & practice

  2. Obesity is linked with a higher risk of metabolic disease in humans (p < 0.05).

    “Men with obesity based on body mass index had a significantly high risk of hypertension, diabetes mellitus, and dyslipidemia across all age groups (all, p < 0.05).”

    Humansmales

    Age-wise examination of the association of obesity based on body mass index and waist circumference with metabolic diseases in comprehensive health checkup participants

    Obesity science & practice

  3. Obesity is linked with a higher risk of metabolic disease in humans (Polish elderly).

    “Being overweight or having obesity, as well as following a diet, increased the probability of being affected by metabolic disease.”

    HumansPolish elderlyn = 417

    Relationship between the Prevalence of Metabolic Disease and Impaired Mobility, Diet, Physical Activity, and Socio-Demographic Characteristics in the Polish Elderly-A Cross-Sectional Study

    Life (Basel, Switzerland)

  4. Obesity raises the risk of metabolic disease in older population.

    “Over half of the global older population were overweight or obese in 2010, significantly increasing the risk of a range of metabolic diseases.”

    Reviewin older population

    Obesity and the dysregulation of fatty acid metabolism: implications for healthy aging

    Expert review of endocrinology & metabolism

More on Obesity

Cellular senescence

upin reviews2mixedin reviews1

3 studies
  1. Cellular senescence raises the risk of metabolic disease.

    “cellular senescence promotes metabolic diseases, which in turn promote senescence.”

    Review

    The metabolic roots of senescence: mechanisms and opportunities for intervention

    Nature metabolism

  2. Cellular senescence is associated with metabolic disease.

    “Evidence suggests that the complex process of senescence is involved in the development of a plethora of chronic diseases including metabolic and inflammatory disorders and tumorigenesis.”

    Review

    The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis

    Hepatology (Baltimore, Md.)

  3. Cellular senescence is associated with metabolic disease (context-dependent protective versus deleterious roles).

    “contradictory findings with regard to a protective versus deleterious role of senescent cells in certain contexts”

    Reviewcontext-dependent protective versus deleterious roles

    Cellular senescence: Implications for metabolic disease

    Molecular and cellular endocrinology

More on Cellular senescence

Estrogen deficiency

upin humans2

2 studies
  1. Estrogen deficiency raises the risk of metabolic disease in humans during menopause.

    “Age-associated loss of estrogen production during menopause has been implicated in a higher risk for metabolic diseases and increased mortality.”

    Reviewduring menopause

    Exploring the effects of estrogen deficiency and aging on organismal homeostasis during menopause

    Nature aging

  2. estrogen deficiency raises the risk of metabolic disease in humans (postmenopausal women).

    “Estrogen deficiency, such as in postmenopausal women, impairs PPAR regulation, leading to lipid accumulation and increased risk of metabolic disorders.”

    Reviewpostmenopausal womenfemales

    Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes

    International journal of molecular sciences

FOXOPROTEINS

upin reviews1mixedin reviews1

2 studies
  1. FOXOPROTEINS is associated with metabolic disease (dysregulation).

    “The dysregulation of FOXO proteins has been established as pivotal in metabolic disorders, human longevity, and the inhibition of tumorigenesis.”

    Reviewdysregulation

    FOXO Transcription Factors: A Brief Overview

    Methods in molecular biology (Clifton, N.J.)

  2. FOXOPROTEINS is associated with metabolic disease.

    “deregulation of FOXO proteins has been shown to play an essential role in metabolic disorders, human longevity, and the suppression of tumors”

    Review

    Introduction to FOXO Biology

    Methods in molecular biology (Clifton, N.J.)

More on FOXOPROTEINS

Diet

upin humans2

2 studies
  1. Diet is associated with metabolic disease in humans (Polish elderly).

    “following a diet, increased the probability of being affected by metabolic disease.”

    HumansPolish elderlyn = 417

    Relationship between the Prevalence of Metabolic Disease and Impaired Mobility, Diet, Physical Activity, and Socio-Demographic Characteristics in the Polish Elderly-A Cross-Sectional Study

    Life (Basel, Switzerland)

  2. Diet is associated with metabolic disease in humans (literature review).

    “Suboptimal nutrition and eating disorders currently reported at both population and individual levels model the effects associated with the risk of metabolic disorders”

    Reviewliterature review

    Obesity and key predictors of its risk

    Voprosy pitaniia

More on Diet

NAD+

upin humans1downin reviews1OR 3.01

2 studies
  1. NAD+ is associated with metabolic disease in humans (Highest versus lowest NAD+ quartile (≤29.4 μmol/L)) (Adjusted OR 3.01 (95% CI 1.87–4.87), highest versus lowest quartile).

    “Increased NAD+ was significantly associated with MD, as well as its individual components.”

    HumansHighest versus lowest NAD+ quartile (≤29.4 μmol/L)whole bloodn = 1,394

    Association of NAD⁺ levels with metabolic disease in a community-based study

    Frontiers in endocrinology

  2. NAD+ is associated with metabolic disease.

    “a decline in NAD levels is closely related to the development of various metabolic disorders, including diabetes and fatty liver disease”

    Review

    Implications of altered NAD metabolism in metabolic disorders

    Journal of biomedical science

More on NAD+

SIRT1

mixedin silico1upin reviews1

2 studies
  1. SIRT1 is associated with metabolic disease in silico (bioinformatic analysis of public gene expression profiles).

    “SIRT1 was associated with obesity-related genes and metabolic disorders.”

    In silicobioinformatic analysis of public gene expression profiles

    Potential biomarkers of Alzheimer's disease and cerebral small vessel disease

    Frontiers in molecular neuroscience

  2. SIRT1 is associated with metabolic disease (aberrant glycosylation).

    “Aberrant glycosylation of SIRT1 is associated with aging and/or metabolic diseases.”

    Reviewaberrant glycosylation

    Temporal gating of SIRT1 functions by O-GlcNAcylation prevents hyperglycemia and enables physiological transitions in liver

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on SIRT1

Sirtuin signaling

downin reviews1mixedin reviews1

2 studies
  1. Sirtuin signaling lowers the risk of metabolic disease.

    “SIRTs play essential roles in ameliorating obesity and age-related metabolic diseases.”

    Review

    Sirtfoods: New Concept Foods, Functions, and Mechanisms

    Foods (Basel, Switzerland)

  2. Sirtuin signaling is associated with metabolic disease.

    “SIRT3, SIRT4, and SIRT5 are implicated in a range of disease-states including metabolic disease such as diabetes, neurodegenerative diseases, cancer, and ageing-related disorders”

    Review

    The role of mitochondrial sirtuins in health and disease

    Free radical biology & medicine

More on Sirtuin signaling

Inflammation

mixedin humans1upin reviews1

2 studies
  1. Inflammation is associated with metabolic disease in humans (multimorbidity).

    “we focus on chronic inflammation as a key common pathological basis of cardiovascular and metabolic diseases”

    Reviewmultimorbidity

    Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity

    Frontiers in cardiovascular medicine

  2. Inflammation raises the risk of metabolic disease.

    “Inflammatory infiltrate and altered immune cell phenotype precede development of metabolic disorders.”

    Review

    Epigenetics and Immunometabolism in Diabetes and Aging

    Antioxidants & redox signaling

More on Inflammation

All 82

Trial sponsors

Funding

65 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$14MNational Heart, Lung, and Blood Institute$6MNational Institute on Aging$1.8M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    In one human study of patients with obesity, vitamin B12 deficiency, vitamin D deficiency and prior underweight are associated with higher metabolic disease risk.

  2. Summary written from the findings.

Latest

Dec 2025: 61Jan 2026: 128Feb 2026: 112Mar 2026: 116Apr 2026: 53May 2026: 61Jun 2026: 75Jul 2026: 76Aug 2026: 70Sep 2026: 67Oct 2026: 103Nov 2026: 62984 papers in 12 months

See all 2,687 papers on metabolic disease